Neurodegeneration 2012
DOI: 10.5772/34949
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Formaldehyde-Mediated Impairments and Age-Related Dementia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 113 publications
0
5
0
Order By: Relevance
“…, ; Khokhlov et al . cited in Miao and He ), and with oxidative damage and impaired energy metabolism (Haider et al . ; Correia et al .…”
Section: Discussionmentioning
confidence: 99%
“…, ; Khokhlov et al . cited in Miao and He ), and with oxidative damage and impaired energy metabolism (Haider et al . ; Correia et al .…”
Section: Discussionmentioning
confidence: 99%
“…Increased expression of formaldehyde‐generating enzymes (Table ) as well as elevated formaldehyde levels have also been reported in brains of patients suffering from neurodegenerative diseases like Alzheimer's disease (AD) or multiple sclerosis (MS) (Khokhlov et al . cited in Miao and He ; Tong et al . , ).…”
Section: Evidence For the Role Of Formaldehyde In Pathologymentioning
confidence: 99%
“…Conditions such as aging and diseases like MS and AD which are associated with increased levels of formaldehyde in brain (Khokhlov et al . cited in Miao and He ; Tong et al . , , b) show impaired mitochondrial function (Sullivan and Brown ; Mahad et al .…”
Section: Formaldehyde‐induced Alterations In Neural Metabolism As Potmentioning
confidence: 99%
“…At the same time, FA is also produced endogenously in the body by demethylase and oxidase enzymes that regulate epigenetics , and metabolism , such as lysine-specific demethylase 1 (LSD1), JmjC domain-containing proteins, and semicarbazide-sensitive amine oxidase . Active degradation by formaldehyde dehydrogenase/ S -nitrosoglutathione reductase and aldehyde dehydrogenase 2 enzymes gives physiological FA levels ranging from 100 μM in blood to 400 μM intracellularly. Elevations of FA and related RCS are implicated in a variety of disease pathologies, including various cancers, neurodegenerative diseases, ,, diabetes, and chronic liver and heart disorders . The rapidly growing list of modified DNA and RNA bases, particularly N-methylated bases whose demethylation pathways may involve FA production, presage a diverse array of important contributions for FA chemistry to biology.…”
mentioning
confidence: 99%